BUSINESSCBS NEWS
Supreme Court rules on fight between drugmakers in "skinny label" patent case
The Supreme Court ruled in favor of a generic drugmaker accused of infringing Amarin Pharma patents related to 'skinny labels.' The decision was reported by CBS News' Jan Crawford.
Mentioned
Related Signal
Adjacent reporting
- How a Supreme Court fight over fish oil could raise your prescription drug costs
- STAT+: Colombia wins a key court ruling over a compulsory license issued for an HIV medicine
- Abortion pill fight heads to Supreme Court as manufacturer warns of ‘chaos’ after ruling
- STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
- STAT+: Supreme Court rejects challenge to Medicare drug price negotiation
- Supreme Court to Hear Arguments in Landmark Roundup Weedkiller Case